Intelligence / Healthtech / FDA 510(k) Clearances / SurGenTec, LLC
Approvalsdevice cleared26 Aug 2026
SurGenTec, LLC
26 Aug 2026: Device cleared · GraftGun Universal Graft Delivery System (GDS®). Recorded in the openFDA device 510(k) data.
- Decided
- 26 Aug 2026
- Device
- GraftGun Universal Graft Delivery System (GDS®)
- Specialty
- General Hospital
- Country
- United States
- Location
- Boca Raton, FL
- Clearance type
- Special
- 510(k) number
- K262581
- Submitted
- 2026-07-27
What this signal means
A clearance starts commercialisation: distribution, reimbursement, software and sales hires.
- 268 added in the 30 days to 9 Nov 2026.
- Cardiovascular leads with 122 clearances, then Radiology (107).
Reach them with AOS
Find the decision makers at SurGenTec, LLC
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
Across AOS Research
Other records for SurGenTec, LLC in our registers.
14 OctSurGenTec, LLCdevice cleared · HealthtechApprovals17 SeptSurGenTec, LLCdevice cleared · HealthtechApprovals24 AugSurGenTec, LLCdevice cleared · HealthtechApprovals
More in General Hospital
FDA 510(k) Clearances
6 NovIcu Medical, Inc.device cleared · CleanBreakApprovals5 NovGlobal Medikit Limiteddevice cleared · Medican Alpha, Medican, Mediflon, Mediflon Quick, Medican Alpha Safety, Medican Safety, Mediflon Safety, Mediflon Safety Quick, Medican Alpha Safety Pro, Medican Safety Pro, Mediflon Safety Pro, Neocan, Enfancie, Neocan safety, Enfancie SafetyApprovals5 NovWest Pharma. Services IL, Ltd.device cleared · Mix2Vial® transfer deviceApprovals30 OctZhejiang Fomos Medical Technology Co., Ltd.device cleared · Foster Plus-22L (SNK/CE-F22)Approvals29 OctLumicare Medtech Co., Ltd.device cleared · Lumicare (ONE);Lumicare (ONE Lite);Lumicare (ONE+)Approvals29 OctSTERISdevice cleared · V-Pro maX 2 Low Temperature Sterilization SystemApprovals
Source: openFDA device 510(k) data, data to 9 Nov 2026. Devices FDA found substantially equivalent and cleared for the US market. Decision dates as published by FDA. AOS shows what the public record says; it does not verify or endorse the company.